Dacarbazine is the drug of choice for the treatment of melanoma in Brazil through the public health system mainly because of its low cost.
IDacarbazine yisidakamizwa esithandwayo ekwelapheni i-melanoma eBrazil ngohlelo lwezempilo lomphakathi ikakhulu ngenxa yezindleko zayo eziphansi.